Cancer cells frequently display intrinsic or acquired resistance to chemically diverse
anticancer drugs, limiting therapeutic success. Among the main mechanisms of this …

Simple Summary Glioblastoma (GBM) is one of the most malignant types of central nervous
system tumor which accounts for more than 60% of all brain tumors in adults. Owing to poor …

Simple Summary Glioma is a type of cancer that is the most common primary brain tumor in
adults. The prognosis is often unfavorable despite early detection and treatment. Therefore …

Small extracellular vesicles (EVs) in the last 20 years are demonstrated to possess
promising properties as potential new drug delivery systems, biomarkers, and therapeutic …

Glioma is the most common and aggressive tumor of the central nervous system. The
uncontrolled proliferation, cellular heterogeneity, and diffusive capacity of glioma cells …

Glioblastoma (GB) is the most common and most aggressive primary brain tumor in adults,
with an overall survival almost 14.6 months. Optimal resection followed by combined …

Gliomas are a primary types of intracranial malignancies and are characterized by a poor
prognosis due to aggressive recurrence profiles. Temozolomide (TMZ) is an auxiliary …

(1) Background: Glioblastoma multiforme (GBM) is the most common and malignant
intracranial tumor in adults. At present, temozolomide (TMZ) is recognized as the preferred …

Glioblastoma multiforme (GBM) is a highly severe primary brain tumor. Despite extensive
research, effective treatments remain elusive. Long noncoding RNAs (lncRNAs) play a …

Glioblastoma (GBM) continues to be the most devastating primary brain malignancy. Despite
significant advancements in understanding basic GBM biology and enormous efforts in …